服务热线
15339069646服务热线
15339069646| Item | Cat. No. | Type | Clone No |
| Anti-MS4A1/CD20 mAbs [Zuberitamab Biosimilar] (MABL-5468) | MABL-5468 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-VTCN1/B7H4;CD3E mAbs [Zubotamig Biosimilar] (MABL-5469) | MABL-5469 | ELISA, FACS, Functional assay, in vivo binding | G1;G1, Kappa;Lambda |
| Anti-EGFR/ERBB1/HER1 mAbs [Zalutumumab Biosimilar] (MABL-5447) | MABL-5447 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-Rabies Virus Spike Glycoprotein G mAbs [Zamerovimab Biosimilar] (MABL-5448) | MABL-5448 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TGM2 mAbs [Zampilimab Biosimilar] (MABL-5449) | MABL-5449 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-Human variable immunoglobulin light chain (N-terminal cryptic neo-epitope) mAbs [Zamubafusp Bio | MABL-5450 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-ERBB2/CD340/HER2;ERBB2/CD340/HER2 mAbs [Zanidatamab Biosimilar] (MABL-5451) | MABL-5451 | ELISA, FACS, Functional assay, in vivo binding | G1;G1, Kappa;Kappa |
| Anti-CD4 mAbs [Zanolimumab Biosimilar] (MABL-5452) | MABL-5452 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-ANGPT2 mAbs [Zansecimab Biosimilar] (MABL-5453) | MABL-5453 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-TFRC/CD71 mAbs [Zeleciment Biosimilar] (MABL-5454) | MABL-5454 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-ADCYAP1R1/PAC1 mAbs [Zelminemab Biosimilar] (MABL-5455) | MABL-5455 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-PDCD1/CD279/PD1 mAbs [Zeluvalimab Biosimilar] (MABL-5456) | MABL-5456 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-F9a;F10 mAbs [Zemocimig Biosimilar] (MABL-5457) | MABL-5457 | ELISA, FACS, Functional assay, in vivo binding | G4;G4, Kappa;Lambda |
| Anti-ERBB3/HER3;ERBB2/CD340/HER2 mAbs [Zenocutuzumab Biosimilar] (MABL-5458) | MABL-5458 | ELISA, FACS, Functional assay, in vivo binding | G1;G1, Kappa;Kappa |
| Anti-IAP/CD47;CD19 mAbs [Zeripatamig Biosimilar] (MABL-5459) | MABL-5459 | ELISA, FACS, Functional assay, in vivo binding | G1;G1, Kappa;Lambda |
| Anti-ANPT2;VEGFA mAbs [Zifibancimig Biosimilar] (MABL-5460) | MABL-5460 | ELISA, FACS, Functional assay, in vivo binding | G1;G1, Kappa;Kappa |
| Anti-TNFSF13/CD256/APRIL mAbs [Zigakibart Biosimilar] (MABL-5461) | MABL-5461 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-IL6 mAbs [Ziltivekimab Biosimilar] (MABL-5462) | MABL-5462 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TNFRSF4/CD134/OX40 mAbs [Vonlerolizumab Biosimilar] (MABL-5430) | MABL-5430 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TNFRSF17/CD269/BCMA/TNFRSF13A;CD3E mAbs [Vonsetamig Biosimilar] (MABL-5431) | MABL-5431 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa;Kappa |
联系我们
Copyright © 2012-2029 西安迈博睿（Mabioway）生物科技有限公司 版权所有
地址：陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话：15339069646 邮箱：info@mabioway.cn